๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Thresholds in disease activity for switching biologics in rheumatoid arthritis patients: Experience from a large US cohort

โœ Scribed by Jie Zhang; Ying Shan; George Reed; Joel Kremer; Jeffrey D. Greenberg; Scott Baumgartner; Jeffrey R. Curtis

Book ID
101402541
Publisher
Wiley (John Wiley & Sons)
Year
2011
Tongue
English
Weight
125 KB
Volume
63
Category
Article
ISSN
2151-464X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Outcomes after switching from one antiโ€“t
Outcomes after switching from one antiโ€“tumor necrosis factor ฮฑ agent to a second antiโ€“tumor necrosis factor ฮฑ agent in patients with rheumatoid arthritis: Results from a large UK national cohort study
โœ Kimme L. Hyrich; Mark Lunt; Kath D. Watson; Deborah P. M. Symmons; Alan J. Silma ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 81 KB ๐Ÿ‘ 1 views

## Abstract ## Objective Patients with rheumatoid arthritis (RA) who experience treatment failure with one antiโ€“tumor necrosis factor (antiโ€TNF) agent, due to either inefficacy or toxicity, are frequently switched to a second antiโ€TNF agent, although the benefits of switching are unknown. The pres